Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an oral dosage form for oral use. It is employed in the management of hypertension, angina pectoris, and certain cardiac arrhythmias, particularly in adult patients requiring cardiovascular rate control. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin, a calcium channel blocker, is used to treat conditions related to elevated vascular tone and abnormal cardiac conduction. Hypertension: lowers blood pressure by dilating peripheral arteries. Angina pectoris: reduces myocardial oxygen demand and improves coronary blood flow. Supraventricular tachyarrhythmias: slows atrioventricular nodal conduction to control heart rate.

Verapamil may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Flushing: transient warmth and redness. - Peripheral edema: swelling of ankles or feet. - Constipation: reduced bowel motility. - Dizziness or light‑headedness: especially on standing. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Bradycardia: markedly slowed heart rate. - Heart block: impaired electrical conduction. - Severe hypotension: dangerous drop in blood pressure. - Hepatotoxicity: abnormal liver function tests. - Allergic reactions: rash, itching, or swelling. - Worsening heart failure: fluid retention or pulmonary edema.

Before initiating therapy with Isoptin, consider the following safety measures. Cardiac function assessment: evaluate for existing heart failure or conduction disorders. Blood pressure monitoring: check baseline and periodic readings. Electrolyte balance: correct significant hypo‑ or hyper‑kalemia. Drug history review: avoid concurrent use with other negative‑inotropic agents. Pregnancy and lactation: discuss risks with a healthcare professional. Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Verapamil interacts with several medicines that can alter its efficacy or safety profile.

Major Interactions (Avoid): - Beta‑blockers (e.g., propranolol): risk of severe bradycardia. - Digoxin: increased serum levels leading to toxicity. - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): markedly raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - Statins metabolized by CYP3A4 (e.g., simvastatin): may increase statin exposure. - Antidiabetic agents (e.g., insulin, sulfonylureas): enhanced hypoglycemic effect. - Diuretics: additive hypotensive effect. - Antihypertensives (e.g., ACE inhibitors): may require dose adjustment.